• Acquisition of SVS, a leading medical device distributor
• Acquisition of Transmedic, a leading medical device distributor in Asia
• Equity raising to fund acquisitions and strengthen balance sheet

EBOS Group Ltd, a leading healthcare and animal care company, has announced the acquisition of two leading medical device distributors, SVS and Transmedic, as well as an equity raising to fund the acquisitions and strengthen its balance sheet. The acquisition of SVS, a leading medical device distributor in Australia and New Zealand, will expand EBOS's presence in the medical device market. The acquisition of Transmedic, a leading medical device distributor in Asia, will provide EBOS with a strategic foothold in the fast-growing Asian market. The equity raising, comprising a placement of new shares to institutional investors and a retail offer to eligible shareholders, will provide the necessary funding to complete the acquisitions and support EBOS's ongoing growth and expansion. The announcement highlights EBOS's strategic focus on strengthening its position in the healthcare and medical device sectors through targeted acquisitions and capital raising initiatives.

EBOS expects the acquisitions to be immediately earnings accretive and contribute to its financial performance in the 2025 financial year.

EBOS is well-positioned to continue its growth trajectory, leveraging the strategic acquisitions of SVS and Transmedic to expand its presence in the medical device market and capitalize on the opportunities in the fast-growing Asian market.